Dr. Saba's academic work focuses on aerodigestive malignancies, namely head and neck and esophageal cancer, as well as the clinical development of novel agents and therapeutic modalities.
Titles and Roles
- Associate Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Chief of Head and Neck Oncology
- Winship Cancer Institute of Emory University
- Research Program
- Discovery and Developmental Therapeutics
Dr. Saba is the principal investigator on several head and neck cancer trials including investigator initiated studies focusing on novel approaches for treating these diseases.
Dr. Saba is a member of the ECOG Head and Neck Cancer steering committee, and an elected member of the American Head and Neck Society (AHNS). He also serves on the American College of Radiology appropriateness criteria panel for Head and Neck Cancer.
Dr. Saba earned his Medical Degree from the American University of Beirut Medical School. He completed a Residency in Internal Medicine at Tufts University School of Medicine in Boston, and Clinical Fellowships in Hematology and Oncology at Brown University School of Medicine and in Bone Marrow Transplant at the University of Toronto Princess Margaret Hospital in Toronto, Canada.
Dr. Saba is a recipient of the following awards:
- NIH grant examining novel genomic approaches for diagnosing HPV positive oropharyngeal cancers
- 2011- Castle Connolly Top Doctors
- 2005- Top Docs in Atlanta
- 2003- Recognition for outstanding contribution to the Fellowship program, University of Minnesota, Hematology Oncology and transplant section
- 1984-1990 Dean's Honor List - American University of Beirut
Dr Saba's research is focused on clinical and translational work in aerodigestive malignancies specifically head and neck, and esophageal cancer. He conducts and leads a number of head and neck cancer clinical trials with a focus on molecular endpoints. He is the co-chair of a number of national cooperative groups trials. He has been a co-investigator on the Department of Defense, USAMRMC grant looking at "Multi-Biomarker System Using Quantum Dot Technology for Assessments of Prognosis of NSCLC" and has served as a co-leader of project 4 of the Emory Head and Neck Cancer SPORE involving the application of nanotherapeutics-based therapy for treating advanced head and neck cancer. His goal is to continue collaborating with basic scientists to advance drug development and clinical trials for head and neck, and esophageal cancers.
Dr. Saba is the author of multiple peer-reviewed articles, editorials, review papers and book chapters. Dr Saba is a member of the editorial board of Oral Oncology, Head Neck as well as the American Journal of Clinical Oncology.